Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.

[1]  Roger. T. Anderson,et al.  Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design. , 2007, The American journal of cardiology.

[2]  J. Williamson,et al.  Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. , 2007, The American journal of cardiology.

[3]  Michael E. Miller,et al.  The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods. , 2007, The American journal of cardiology.

[4]  J. Cutler,et al.  Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. , 2007, The American journal of cardiology.

[5]  Lawrence A Leiter,et al.  Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. , 2007, The American journal of cardiology.

[6]  H. Gerstein,et al.  Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. , 2007, The American journal of cardiology.

[7]  W. Ambrosius,et al.  Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE). , 2007, The American journal of cardiology.

[8]  W. Cushman,et al.  Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. , 2007, The American journal of cardiology.

[9]  J. Rosenstock,et al.  Prevention of cardiovascular outcomes in type 2 diabetes mellitus: trials on the horizon. , 2005, Endocrinology and metabolism clinics of North America.

[10]  T. Gilmer,et al.  Predictors of health care costs in adults with diabetes. , 2005, Diabetes care.

[11]  Desmond E. Williams,et al.  Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000. , 2004, American journal of epidemiology.

[12]  M. Engelgau,et al.  The Evolving Diabetes Burden in the United States , 2004, Annals of Internal Medicine.

[13]  E. Barrett-Connor,et al.  Women and heart disease: the role of diabetes and hyperglycemia. , 2004, Archives of internal medicine.

[14]  S. Saydah,et al.  Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. , 2004, JAMA.

[15]  G. Eknoyan,et al.  National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.

[16]  Plamen Nikolov,et al.  Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.

[17]  Anke Richter,et al.  Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. , 2002, JAMA.

[18]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  R. Holman,et al.  Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23) , 1998, BMJ.

[20]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[21]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[22]  D. Cox.  Regression Models and Life-Tables , 1972 .

[23]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .